marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-06-2024
Teva Pharmaceutical Industries Limited Financial Statements 2011-2024 | TEVA
Annual Financial Statements Teva Pharmaceutical Industries Limited
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
14.5 B | 11.4 B | 9.29 B | 12.9 B | 11.2 B | 20.4 B | 21 B | 31.9 B | 49.4 B | 44.6 B | 34.7 B | 28.3 B | 33.8 B |
Shares |
1.12 B | 1.11 B | 1.1 B | 1.1 B | 1.09 B | 1.02 B | 1.02 B | 955 M | 855 M | 853 M | 849 M | 872 M | 890 M |
Historical Prices |
13 | 10.3 | 8.43 | 11.8 | 10.4 | 19.9 | 20.3 | 32 | 57.5 | 52 | 39.6 | 32.7 | 38 |
Net Income |
-559 M | -1.3 B | 417 M | -3.99 B | -999 M | -2.15 B | -16.3 B | 329 M | 1.59 B | 3.06 B | 1.27 B | 1.96 B | 2.76 B |
Revenue |
15.8 B | 14.9 B | 15.9 B | 16.7 B | 16.9 B | 18.9 B | 22.4 B | 21.9 B | 19.7 B | 20.3 B | 20.3 B | 20.3 B | 18.3 B |
Cost of Revenue |
8.2 B | 7.95 B | 8.28 B | 8.93 B | 9.35 B | 9.98 B | 11.2 B | 10.2 B | 8.3 B | 9.22 B | 9.61 B | 9.66 B | 8.8 B |
Gross Profit |
7.64 B | 6.97 B | 7.59 B | 7.73 B | 7.54 B | 8.3 B | 10.8 B | 11.9 B | 11.4 B | 11.1 B | 10.7 B | 10.7 B | 9.52 B |
Operating Income |
433 M | -940 M | 1.72 B | -3.57 B | -443 M | -1.64 B | -17.5 B | 2.15 B | 3.35 B | 3.95 B | 1.65 B | 2.2 B | 3.11 B |
Interest Expense |
1.03 B | 930 M | 891 M | 901 M | 822 M | 920 M | 875 M | 546 M | 270 M | 300 M | 314 M | 355 M | 234 M |
EBITDA |
1.59 B | 368 M | 3.05 B | -2.02 B | 1.28 B | 205 M | 6.1 B | 6.18 B | 6.42 B | 6 B | 5.6 B | 5.89 B | 5.08 B |
Operating Expenses |
- | - | - | - | 4.79 B | 5.41 B | 6.83 B | 7.21 B | 6.24 B | 6.57 B | 6.75 B | 6.47 B | 5.5 B |
General and Administrative Expenses |
1.16 B | 1.18 B | 1.1 B | 1.17 B | 1.19 B | 1.3 B | 1.33 B | 1.24 B | 1.24 B | 1.22 B | 1.24 B | 1.24 B | 932 M |
All numbers in USD currency
Quarterly Income Statement Teva Pharmaceutical Industries Limited
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
1.13 B | 1.13 B | 1.12 B | 1.12 B | 1.12 B | 1.12 B | - | 1.11 B | 1.11 B | 1.11 B | - | 1.1 B | 1.1 B | 1.1 B | - | 1.1 B | 1.1 B | 1.09 B | - | 1.09 B | 1.09 B | 1.09 B | - | 1.02 B | 1.02 B | 1.02 B | - | 1.02 B | 1.02 B | 1.02 B | - | 979 M | 914 M | 913 M | - | 851 M | 849 M | 851 M | - | 855 M | 852 M | 850 M | - | 845 M | 849 M | 855 M | - | 869 M | 871 M | 880 M | - | 888 M | 892 M | 897 M |
Net Income |
-437 M | -846 M | -139 M | 69 M | -872 M | -220 M | - | 56 M | -232 M | -955 M | - | 292 M | 207 M | 77 M | 150 M | -4.35 B | 140 M | 69 M | 110 M | -314 M | -689 M | -105 M | -2.89 B | -208 M | -176 M | 1.12 B | -11.5 B | 595 M | -5.97 B | 645 M | - | 412 M | 254 M | 636 M | - | 103 M | 539 M | 446 M | - | 876 M | 748 M | 744 M | - | 711 M | -452 M | 630 M | - | -79 M | 863 M | 859 M | - | 916 M | 576 M | 761 M |
Revenue |
4.33 B | 4.16 B | 3.82 B | 3.85 B | 3.88 B | 3.66 B | - | 3.6 B | 3.79 B | 3.66 B | - | 3.89 B | 3.91 B | 3.98 B | 4.45 B | 3.98 B | 3.87 B | 4.36 B | 4.47 B | 4.09 B | 4.18 B | 4.15 B | 4.42 B | 4.38 B | 4.55 B | 5.06 B | 5.46 B | 5.61 B | 5.72 B | 5.65 B | 6.49 B | 5.56 B | 5.04 B | 4.81 B | - | 4.82 B | 4.97 B | 4.98 B | - | 5.06 B | 5.04 B | 5 B | - | 5.06 B | 4.92 B | 4.9 B | - | 4.97 B | 4.99 B | 4.99 B | - | 4.34 B | 4.21 B | 4.08 B |
Cost of Revenue |
2.18 B | 2.14 B | 2.05 B | 2 B | 2.08 B | 2.08 B | - | 1.93 B | 1.99 B | 1.92 B | - | 2.09 B | 2.04 B | 2.1 B | - | 2.13 B | 2.11 B | 2.29 B | - | 2.26 B | 2.28 B | 2.29 B | - | 2.55 B | 2.67 B | 2.75 B | - | 2.97 B | 2.86 B | 2.81 B | - | 2.76 B | 2.16 B | 2.02 B | - | 2.05 B | 2.06 B | 2.15 B | - | 2.25 B | 2.38 B | 2.3 B | - | 2.43 B | 2.33 B | 2.31 B | - | 2.37 B | 2.34 B | 2.49 B | - | 2.1 B | 2.01 B | 1.89 B |
Gross Profit |
2.15 B | 2.02 B | 1.77 B | 1.85 B | 1.8 B | 1.58 B | - | 1.67 B | 1.79 B | 1.74 B | - | 1.79 B | 1.87 B | 1.88 B | 2.05 B | 1.85 B | 1.76 B | 2.06 B | 1.96 B | 1.83 B | 1.89 B | 1.86 B | 1.97 B | 1.98 B | 2.03 B | 2.32 B | 2.44 B | 2.6 B | 2.8 B | 2.77 B | 3.39 B | 2.8 B | 2.88 B | 2.79 B | - | 2.77 B | 2.9 B | 2.84 B | - | 2.81 B | 2.66 B | 2.7 B | - | 2.63 B | 2.59 B | 2.59 B | - | 2.6 B | 2.66 B | 2.61 B | - | 2.25 B | 2.2 B | 2.19 B |
Operating Income |
-51 M | -5 M | -218 M | 344 M | -654 M | -13 M | - | 419 M | -949 M | -713 M | - | 623 M | 582 M | 434 M | - | -4.34 B | 173 M | 191 M | - | -81 M | -644 M | 134 M | - | 16 M | -14 M | 1.52 B | - | 378 M | -5.74 B | 895 M | - | 765 M | 361 M | 1.16 B | - | 1.01 B | 662 M | 749 M | - | 1.11 B | 925 M | 972 M | - | 801 M | -586 M | 874 M | - | -60 M | 1.01 B | 928 M | - | 1.04 B | 597 M | 867 M |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
208 M | 254 M | 54 M | 627 M | -354 M | 291 M | - | 740 M | -591 M | -390 M | - | 1.63 B | 755 M | 810 M | - | -3.18 B | 954 M | 590 M | - | 1.22 B | 249 M | 577 M | - | 1.48 B | 972 M | 2.03 B | - | 1.96 B | -4.68 B | 1.38 B | - | 765 M | 361 M | 1.47 B | - | 1.01 B | 662 M | 1.08 B | - | 1.11 B | 925 M | 1.38 B | - | 801 M | -586 M | 1.26 B | - | -60 M | 1.01 B | 1.45 B | - | 1.04 B | 597 M | 1.13 B |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
298 M | 283 M | 278 M | 268 M | 307 M | 296 M | - | 283 M | 313 M | 296 M | - | 291 M | 242 M | 290 M | - | 279 M | 264 M | 304 M | - | 285 M | 296 M | 292 M | - | 309 M | 316 M | 329 M | - | 372 M | 363 M | 366 M | - | 310 M | 311 M | 304 M | - | 316 M | 325 M | 307 M | - | 293 M | 302 M | 302 M | - | 297 M | 319 M | 307 M | - | 292 M | 316 M | 312 M | - | 112 M | 284 M | 221 M |
All numbers in USD currency